Evaluation of the Cochrane Collaboration's tool for assessing the risk of bias in randomized trials: Focus groups, online survey, proposed recommendations and their implementation

Systematic Reviews

Volumn 3, Issue 1, 2014, Pages

  Savović, Jelena ^a   Weeks, Laura ^b   Sterne, Jonathan A C ^a   Turner, Lucy ^c   Altman, Douglas G ^d   Moher, David ^c,e   Higgins, Julian P T ^a,f  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b Ottawa Integrative Cancer Centre   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Bias assessment; Focus groups; Quality assessment; Survey; Systematic reviews

Indexed keywords

ARTICLE; COCHRANE LIBRARY; HEALTH SURVEY; HUMAN; INTENTION TO TREAT ANALYSIS; OUTCOME ASSESSMENT; PERCEPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; RISK OF BIAS; SEMI STRUCTURED INTERVIEW; SENSITIVITY ANALYSIS; WORKLOAD; EVALUATION STUDY; EVIDENCE BASED MEDICINE; INFORMATION PROCESSING; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; STANDARD; STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); DATA COLLECTION; EVIDENCE-BASED MEDICINE; FOCUS GROUPS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT;

EID: 84907273866     PISSN: None     EISSN: 20464053     Source Type: Journal    
DOI: 10.1186/2046-4053-3-37     Document Type: Article

References (21)

1. Savović J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, Als-Nielsen B, Balk EM, Gluud C, Gluud LL, Ioannidis JP, Schulz KF, Beynon R, Welton NJ, Wood L, Moher D, Deeks JJ, Sterne JA. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann Intern Med 2012, 157:429-438. 10.7326/0003-4819-157-6-201209180-00537, 22945832.
2. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. J Am Med Assoc 1995, 273:408-412.
3. Wood L, Egger M, Gluud LL, Schulz KF, Juni P, Altman DG, Gluud C, Martin RM, Wood AJ, Sterne JA. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008, 336:601-605. 10.1136/bmj.39465.451748.AD, 2267990, 18316340.
4. Lundh A, Gotzsche PC. Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies. BMC Med Res Methodol 2008, 8:22. 10.1186/1471-2288-8-22, 2375895, 18426565.
5. Juni P, Altman DG, Egger M. Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46. 10.1136/bmj.323.7303.42, 1120670, 11440947.
6. Higgins JPT, Altman DG. Chapter 8: assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions 2008, 187-241. Chichester: John Wiley & Sons Ltd, Higgins JPT, Green S.
7. Review Manager (RevMan) Computer Program 2008, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, Version 5.0, Review Manager (RevMan).
8. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions 2011, Oxford: The Cochrane Collaboration, Version 5.1.0 (updated March 2011).
9. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA, . Cochrane Bias Methods Group; Cochrane Statistical Methods Group The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011, 343:d5928. 10.1136/bmj.d5928, 3196245, 22008217, Cochrane Bias Methods Group; Cochrane Statistical Methods Group.
10. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010, 25:603-605. 10.1007/s10654-010-9491-z, 20652370.
11. Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta-analyses 2012, Ottawa, ON: Ottawa Hospital Research Institute.
12. Cochrane Effective Practice and Organisation of Care Review Group Data Collection Checklist 2012, Ottawa, ON: Ottawa Hospital Research Institute, Cochrane Effective Practice and Organisation of Care Review Group.
13. Review Manager (RevMan) Computer Program 2011, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, Version 5.1, Review Manager (RevMan).
14. Bafeta A, Dechartres A, Trinquart L, Yavchitz A, Boutron I, Ravaud P. Impact of single centre status on estimates of intervention effects in trials with continuous outcomes: meta-epidemiological study. BMJ 2012, 344:e813. 10.1136/bmj.e813, 3279328, 22334559.
15. Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels-Ansdell D, Walter SD, Guyatt GH, Flynn DN, Elamin MB, Murad MH, Abu Elnour NO, Lampropulos JF, Sood A, Mullan RJ, Erwin PJ, Bankhead CR, Perera R, Ruiz Culebro C, You JJ, Mulla SM, Kaur J, Nerenberg KA, Schünemann H, Cook DJ, Lutz K, Ribic CM, Vale N, et al. STOPIT-2 Study Group Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 2010, 303:1180-1187. 10.1001/jama.2010.310, 20332404, STOPIT-2 Study Group.
16. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012, 12. MR000033.
17. Hartling L, Ospina M, Liang Y, Dryden DM, Hooton N, Krebs Seida J, Klassen TP. Risk of bias versus quality assessment of randomised controlled trials: cross sectional study. BMJ 2009, 339:b4012. 10.1136/bmj.b4012, 2764034, 19841007.
18. Pildal J, Hrobjartsson A, Jorgensen KJ, Hilden J, Altman DG, Gotzsche PC. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007, 36:847-857. 10.1093/ije/dym087, 17517809.
19. Hartling L, Bond K, Vandermeer B, Seida J, Dryden DM, Rowe BH. Applying the risk of bias tool in a systematic review of combination long-acting beta-agonists and inhaled corticosteroids for persistent asthma. PLoS One 2011, 6:e17242. 10.1371/journal.pone.0017242, 3044729, 21390219.
20. Liu Y, Yang S, Dai J, Xu Y, Zhang R, Jiang H, Yan X, Yang K. Risk of bias tool in systematic reviews/meta-analyses of acupuncture in Chinese journals. PLoS One 2011, 6:e28130. 10.1371/journal.pone.0028130, 3235108, 22174772.
21. Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, Leeflang MM, Sterne JA, Bossuyt PM, . QUADAS-2 Group QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011, 155:529-536. 10.7326/0003-4819-155-8-201110180-00009, 22007046, QUADAS-2 Group.